KODK

Eastman Kodak Company 1995 Annual Report (10-K) Summary

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended December 31, 1995. Eastman Kodak Company is primarily engaged in developing, manufacturing, and marketing consumer and commercial imaging products. The company operates two main segments: Consumer Imaging (amateur photography, films, papers, photofinishing) and Commercial Imaging (professional, medical, motion picture, and office automation products). The company has significantly restructured its portfolio in recent years, divesting its non-imaging health businesses in 1994 and spinning off its chemical business (Eastman Chemical Company) in 1993.

Key Financial Metrics (1995)

Material Changes vs. Prior Period

• Revenue Growth: Sales from continuing operations increased 10% to $14.98 billion, driven primarily by higher unit volumes in both Consumer and Commercial segments. Foreign currency fluctuations favorably impacted sales by $453 million.
• Profitability Surge: Net earnings rose significantly to $1.252 billion ($3.67 per share) compared to $557 million ($1.66 per share) in 1994. This improvement was largely due to the absence of the $340 million in restructuring costs and $110 million in financial instrument losses recorded in 1994.
• Segment Performance:
  • Consumer Imaging: Sales increased 15% to $6.83 billion; operating earnings increased 46% to $1.282 billion.
  • Commercial Imaging: Sales increased 7% to $8.18 billion; operating earnings increased 53% to $659 million.
• Debt Reduction: Total borrowings decreased to $1.251 billion in 1995 from $1.031 billion in 1994, following significant debt extinguishment in 1994 using proceeds from health business divestitures.

Guidance, Outlook, and Risks

• Office Imaging Strategy: In January 1996, management announced it is exploring strategic alternatives for its Office Imaging business, including potential divestiture, joint ventures, or alliances, to strengthen and reposition the segment.
• Capital Allocation: The company commenced a $1 billion stock repurchase program in Q4 1995, having repurchased $300 million by year-end. Additionally, $500 million of stock was contributed to the U.S. pension plan.
• Environmental Liabilities: Kodak faces ongoing environmental compliance costs. A 1994 settlement with the EPA regarding the Kodak Park site requires a 12-year compliance schedule with costs that cannot currently be reasonably estimated. Remediation reserves stood at $114 million at year-end 1995.
• Legal Proceedings: The company is defending antitrust litigation (Image Technical Service, et al.) where a jury verdict of approximately $24 million (pre-trebling) was reached in 1995; Kodak intends to appeal. Two similar cases are pending.
• Restructuring: Remaining reserves for restructuring programs were $234 million at year-end 1995, down from $538 million in 1994.

Investor Verification Checklist

• Office Imaging Divestiture: Verify the status and potential financial impact of the announced strategic review of the Office Imaging business.
• Environmental Costs: Monitor the finalization of the RCRA Facility Investigation (RFI) at Kodak Park to assess potential future capital expenditures for remediation.
• Antitrust Litigation: Track the appeal process of the Image Technical Service verdict and the status of the Nationwide and A-1 Copy Center cases.
• Stock Repurchase Execution: Confirm the pace and completion of the remaining $700 million in the authorized stock repurchase program.
• Postretirement Benefits: Review the sensitivity of the $2.9 billion accrued postretirement benefit obligation to changes in health care cost trend rates and discount rates.